Cargando…
Advances in immunology. Volume 56
A Leader in Immunology.
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
San Diego ; New York ; Boston :
Academic Press,
�1994.
|
| Colección: | Advances in immunology.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn298976013 | ||
| 003 | OCoLC | ||
| 005 | 20231117015206.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 090121s1994 caua ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d UBY |d IDEBK |d E7B |d OCLCQ |d OPELS |d OCLCQ |d OCLCF |d EBLCP |d YDXCP |d OCLCQ |d YDX |d MERUC |d DEBBG |d OTZ |d LEAUB |d OCLCQ |d OCLCO |d COM |d OCLCO |d OCL |d OCLCQ |d OCLCO | ||
| 019 | |a 505076343 |a 646759250 |a 808731295 | ||
| 020 | |a 9780080578323 |q (electronic bk.) | ||
| 020 | |a 0080578322 |q (electronic bk.) | ||
| 020 | |a 0120224569 |q (electronic bk.) | ||
| 020 | |a 9780120224562 |q (electronic bk.) | ||
| 035 | |a (OCoLC)298976013 |z (OCoLC)505076343 |z (OCoLC)646759250 |z (OCoLC)808731295 | ||
| 050 | 4 | |a QR181 |b .A38eb vol. 56 | |
| 072 | 7 | |a MED |x 044000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.07/9 |2 22 |
| 096 | |a QW 504 |f ADV | ||
| 245 | 0 | 0 | |a Advances in immunology. |n Volume 56 |h [electronic resource] / |c edited by Frank J. Dixon. |
| 260 | |a San Diego ; |a New York ; |a Boston : |b Academic Press, |c �1994. | ||
| 300 | |a 1 online resource (viii, 501 pages) : |b illustrations. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Advances in Immunology ; |v v.56 | |
| 504 | |a Includes bibliographical references and index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Advances in Immunology, Volume 56; Copyright Page; Contents; Chapter 1. Properties and Functions of Interleukin-10; I. Introduction; II. Discovery; III. Physical Properties; IV. cDNA Cloning; V. Gene Structure; VI. Production; VII. Biological Effects of ILl0; VIII. Two Herpesviruses Have Acquired an ILl0 Gene; IX. Functional Similarities between ILl0 and Other TH2 Cytokines; X. Expression of ILl0 Correlates with TH2 Responses; XI. Effects of in Vivo Manipulation of ILl0 Levels; XII. ILl0 in Pregnancy; XIII. The ILl0 Receptor; XIV. Conclusions; References. | |
| 505 | 8 | |a Chapter 2. The Mechanism of V(D)J Joining: Lessons from Molecular, Immunological, and Comparative AnalysesI. Introduction; II. V(D)J Joining Basics; III. The Endogenous Substrate; IV. Model Systems; V. Fine-Structure of Recombinants: Clues to the Mechanism; VI. Agents of Joining; VII. The Origins of Order in V(D)J Joining; VIII. Fidelity and Pathogenesis; IX. The Joining Mechanism: A Working Hypothesis; X. Conclusion; Appendix; References; Chapter 3. Involvement of the Protein Tyrosine Kinase p56lck in T Cell Signaling and Thymocyte Development; I. Introduction. | |
| 505 | 8 | |a II. Regulation of lck ExpressionIII. Regulation of p56lck; IV. Signal Transduction via p56lck; V. Participation of p56lck in T Cell Signaling; VI. Involvement of p56lck in the Control of Thymocyte Development; VII. Future Directions; References; Chapter 4. Generating the Antibody Repertoire in Rabbit; I. Introduction; II. B Lymphocyte Development; III. Ig Genes and Gene Rearrangements; IV. Development of the Antibody Repertoire; V. GALT and the Antibody Repertoire; VI. Summary; References; Chapter 5. Immunotherapeutic Strategies Directed at the Trimolecular Complex; I. Introduction. | |
| 505 | 8 | |a II. Target 1: The T CellIII. Target 2: The Peptide Antigen; IV. Target 3: The MHC (la) Molecule; V. Conclusion; References; Chapter 6. Therapeutic Regulation of the Complement System in Acute Injury States; I. Introduction; II. An Overview of Complement Activation; III. Clinical Assessment of Complement Activation; IV. Intrinsic Regulation of Complement Activation; V. Interactions between Leukocytes and Complement; VI. Complement Deficiency States; VII. Clinical Injury and Acute Complement Activation (Failures of Intrinsic Regulation?); VIII. Therapeutic Complement Inhibition Using sCRl. | |
| 505 | 8 | |a IX. Therapeutic Complement Inhibition Using Other AgentsX. Summary; References; Chapter 7. Chemoimmunoconjugates for the Treatment of Cancer; I. Introduction: Concept of Targeted Chemotherapy; II. Monoclonal Antibodies as Carriers; III. Conjugation Chemistry; IV. Drug-Monoclonal Antibody Conjugates; V. Mode of Action of Drug-Monoclonal Antibody Conjugates; VI. Barriers to Antibody-Targeted Chemotherapy; VII. Clinical Trials; VIII. Conclusion; References; Chapter 8. The Molecular Basis of Susceptibility to Rheumatoid Arthritis; I. Overview; II. Objectives. | |
| 520 | |a A Leader in Immunology. | ||
| 650 | 0 | |a Immunology. | |
| 650 | 2 | |a Allergy and Immunology |0 (DNLM)D000486 | |
| 650 | 4 | |a Allergy and immunology |v Periodicals. | |
| 650 | 4 | |a Allergy and immunology. | |
| 650 | 4 | |a Immunity. | |
| 650 | 4 | |a Immunologic diseases. | |
| 650 | 4 | |a Immunology |v Periodicals. | |
| 650 | 4 | |a Immunology. | |
| 650 | 6 | |a Immunologie. |0 (CaQQLa)201-0066630 | |
| 650 | 7 | |a MEDICAL |x Immunology. |2 bisacsh | |
| 650 | 7 | |a Immunology |2 fast |0 (OCoLC)fst00968006 | |
| 650 | 7 | |a Immunit�e. |2 fmesh | |
| 655 | 2 | |a Periodical |0 (DNLM)D020492 | |
| 655 | 7 | |a periodicals. |2 aat |0 (CStmoGRI)aatgf300026657 | |
| 655 | 7 | |a Periodicals |2 fast |0 (OCoLC)fst01411641 | |
| 655 | 7 | |a Periodicals. |2 lcgft | |
| 655 | 7 | |a P�eriodiques. |2 rvmgf |0 (CaQQLa)RVMGF-000001105 | |
| 700 | 1 | |a Dixon, Frank J. |q (Frank James), |d 1920-2008. | |
| 776 | 0 | 8 | |i Print version: |t Advances in immunology. Volume 56. |d San Diego ; New York ; Boston : Academic Press, �1994 |z 0120224569 |z 9780120224562 |w (OCoLC)31138506 |
| 830 | 0 | |a Advances in immunology. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780120224562 |z Texto completo |